Application case

應(yīng)用案例

Instrument reward

儀器大賞

  • 智能化共聚焦高內(nèi)涵成像分析系統(tǒng)

    lmageXpressConfocal HT.ai

  • 共聚焦高內(nèi)涵成像系統(tǒng)

    lmageXpress Micro Confocal

  • 寬場高內(nèi)涵成像系統(tǒng)

    lmageXpress Micro 4

  • 自動化細(xì)胞成像分析系統(tǒng)

    lmageXpress Pico

Imaging classroom

高內(nèi)涵成像小課堂

  • 體外腫瘤研究新方法-高內(nèi)涵成像分析技術(shù)

  • 高內(nèi)涵3D顯微成像和自動化分析技術(shù)實驗應(yīng)用

  • AI技術(shù)加持的高內(nèi)涵高階圖像分析技術(shù)

  • 基于形態(tài)學(xué)的中藥藥效評價和篩選

database

資料庫

Published literature

發(fā)表文獻(xiàn)

  • Cecioni S, Ashmus R A, Gilormini P A, et al. Quantifying lysosomal glycosidase activity within cells using bis-acetal substrates[J]. Nature Chemical Biology. 2022, 18(3):332-341.
  • Zhuo W, Sun M, Wang K, et al. m6Am methyltransferase PCIF1 is essential for aggressiveness of gastric cancer cells by inhibiting TM9SF1 mRNA translation[J]. Cell discovery, 2022, 8(1): 1-17.
  • Hiller B M, Marmion D J, Thompson C A, et al. Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson’s disease[J]. NPJ Regenerative medicine, 2022, 7(1): 1-15.
  • Sun S, Gao T, Pang B, et al. RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m6A-dependent manner[J]. Cell Death & Disease, 2022, 13(1): 1-14.
  • Onyenwoke R U, Leung T C, Huang X, et al. An assessment of vaping-induced inflammation and toxicity: A feasibility study using a 2-stage zebrafish and mouse platform[J]. Food and Chemical Toxicology, 2022, 163: 112923.
  • Liu Z, Ramirez A, Liu X. Live Cell Imaging of Spatiotemporal Ca 2+ Fluctuation Responses to Anticancer Drugs[M]//TGF-Beta Signaling. Humana, New York, NY, 2022: 227-236.
  • Hong M H, Weng I, Li F Y, et al. Visualization of Cytosolic Galectin Accumulation Around Damaged Vesicles and Organelles[M]//Galectins. Humana, New York, NY, 2022: 353-365.
  • Vranic M, Ferreira V, Hetty S, et al. Aripiprazole, But Not Olanzapine, Directly Inhibits Human Adipocyte Differentiation and Glucose Metabolism[J].
  • Vranic M, Ferreira V, Hetty S, et al. Aripiprazole, But Not Olanzapine, Directly Inhibits Human Adipocyte Differentiation and Glucose Metabolism[J].
  • Vranic M, Ferreira V, Hetty S, et al. Aripiprazole, But Not Olanzapine, Directly Inhibits Human Adipocyte Differentiation and Glucose Metabolism[J].
  • Vranic M, Ferreira V, Hetty S, et al. Aripiprazole, But Not Olanzapine, Directly Inhibits Human Adipocyte Differentiation and Glucose Metabolism[J].
  • Vranic M, Ferreira V, Hetty S, et al. Aripiprazole, But Not Olanzapine, Directly Inhibits Human Adipocyte Differentiation and Glucose Metabolism[J].
related articles

相關(guān)文章

about us

企業(yè)介紹

美谷分子儀器(上海)有限公司

Molecular Devices 始創(chuàng)于上世紀(jì)80年代美國硅谷,并在全球設(shè)有多個代表處和子公司。2005年,Molecular Devices 在上海設(shè)立了中國代表處,2010年加入全球科學(xué)與技術(shù)的創(chuàng)新者丹納赫集團(tuán),2011年正式成立商務(wù)公司:美谷分子儀器 (上海) 有限公司,F(xiàn)在,美谷分子與IDT埃德特、貝克曼庫爾特生命科學(xué)、愛博才思、艾杰爾-飛諾美、徠卡顯微系統(tǒng)、頗爾等公司均隸屬于丹納赫集團(tuán)生命科學(xué)平臺旗下運(yùn)營公司。作為全球高通量儀器設(shè)備的優(yōu)秀品牌,Molecular Devices以持續(xù)創(chuàng)新、快速高效、高性能的產(chǎn)品及完善的售后服務(wù)著稱業(yè)內(nèi)。Molecular Devices一直致力于為客戶提供在生命科學(xué)研究、制藥及生物治療開發(fā)等域蛋白和細(xì)胞生物學(xué)的創(chuàng)新性生物分析解決方案。產(chǎn)品線覆蓋微孔板讀板機(jī)、GxP合規(guī)軟件、洗板機(jī)、高內(nèi)涵細(xì)胞成像系統(tǒng)、克隆篩選系統(tǒng)、高通量實時熒光檢測分析系統(tǒng)、微陣列掃描儀、膜片鉗及檢測試劑..

查看詳情

關(guān)于阿儀 | 本站服務(wù) | 廣告服務(wù) | 智能建站 | 聯(lián)系我們

Copyright 2009-2022 app17.com,all rights reserved   ICP備案號:浙ICP備08105869號

掃碼加我

我要采購